Skip to content

US · CTOR

Citius Oncology, Inc.

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Drug Manufacturers - General
Headquarters
Cranford, NY 07016

Price · as of 2026-09-03

$0.79

Market cap 70.01M

Price history

Weekly OHLC price history for CTOR, USD per share
WeekOpenHighLowCloseVolume
Jul 22, 2024 – Jul 26, 2024$11.43$11.54$11.42$11.480
Jul 29, 2024 – Aug 2, 2024$11.44$13.97$9.54$12.310
Aug 5, 2024 – Aug 9, 2024$15.73$49.00$12.94$40.500
Aug 12, 2024 – Aug 16, 2024$40.50$40.50$1.88$2.000
Aug 19, 2024 – Aug 23, 2024$1.96$2.15$1.67$1.870
Aug 26, 2024 – Aug 30, 2024$1.90$2.10$1.53$1.770
Sep 2, 2024 – Sep 6, 2024$1.75$1.93$1.65$1.770
Sep 9, 2024 – Sep 13, 2024$1.73$1.79$1.59$1.630
Sep 16, 2024 – Sep 20, 2024$1.69$1.73$1.51$1.600
Sep 23, 2024 – Sep 27, 2024$1.86$1.91$1.30$1.400
Sep 30, 2024 – Oct 4, 2024$1.41$1.44$1.11$1.190
Oct 7, 2024 – Oct 11, 2024$1.17$1.18$0.93$1.010
Oct 14, 2024 – Oct 18, 2024$1.02$1.36$0.94$1.240
Oct 21, 2024 – Oct 25, 2024$1.29$1.40$1.13$1.190
Oct 28, 2024 – Nov 1, 2024$1.21$1.27$1.13$1.140
Nov 4, 2024 – Nov 8, 2024$1.11$1.39$1.01$1.270
Nov 11, 2024 – Nov 15, 2024$1.29$1.45$1.03$1.060
Nov 18, 2024 – Nov 22, 2024$1.04$1.07$0.85$0.850
Nov 25, 2024 – Nov 29, 2024$0.91$1.07$0.85$0.920
Dec 2, 2024 – Dec 6, 2024$0.91$2.33$0.90$1.440
Dec 9, 2024 – Dec 13, 2024$1.40$1.41$1.02$1.110
Dec 16, 2024 – Dec 20, 2024$1.07$1.20$0.95$0.980
Dec 23, 2024 – Dec 27, 2024$0.96$1.09$0.93$1.040
Dec 30, 2024 – Jan 3, 2025$1.16$1.35$1.06$1.300
Jan 6, 2025 – Jan 10, 2025$1.50$1.64$1.12$1.150
Jan 13, 2025 – Jan 17, 2025$1.19$1.39$1.02$1.270
Jan 20, 2025 – Jan 24, 2025$1.27$1.35$1.16$1.250
Jan 27, 2025 – Jan 31, 2025$1.27$1.35$1.12$1.200
Feb 3, 2025 – Feb 7, 2025$1.16$1.35$1.15$1.180
Feb 10, 2025 – Feb 14, 2025$1.19$1.33$1.15$1.250
Feb 17, 2025 – Feb 21, 2025$1.22$1.28$1.15$1.170
Feb 24, 2025 – Feb 28, 2025$1.17$1.29$1.10$1.190
Mar 3, 2025 – Mar 7, 2025$1.14$1.17$0.91$0.940
Mar 10, 2025 – Mar 14, 2025$0.96$0.96$0.69$0.730
Mar 17, 2025 – Mar 21, 2025$0.73$0.75$0.55$0.620
Mar 24, 2025 – Mar 28, 2025$0.65$0.98$0.59$0.670
Mar 31, 2025 – Apr 4, 2025$1.00$1.17$0.60$0.690
Apr 7, 2025 – Apr 11, 2025$0.61$0.73$0.60$0.670
Apr 14, 2025 – Apr 17, 2025$0.68$0.74$0.62$0.670
Apr 21, 2025 – Apr 25, 2025$0.65$0.74$0.62$0.730
Apr 28, 2025 – May 2, 2025$0.71$0.98$0.69$0.930
May 5, 2025 – May 9, 2025$0.92$0.95$0.82$0.850
May 12, 2025 – May 16, 2025$0.85$0.95$0.83$0.900
May 19, 2025 – May 23, 2025$0.92$0.94$0.86$0.910
May 26, 2025 – May 30, 2025$0.95$0.95$0.83$0.900
Jun 2, 2025 – Jun 6, 2025$0.90$1.09$0.86$1.050
Jun 9, 2025 – Jun 13, 2025$1.23$1.52$1.09$1.470
Jun 16, 2025 – Jun 20, 2025$1.47$3.43$1.23$2.630
Jun 23, 2025 – Jun 27, 2025$2.83$6.19$2.37$4.500
Jun 30, 2025 – Jul 3, 2025$4.52$5.89$4.06$5.290
Jul 7, 2025 – Jul 11, 2025$5.23$5.24$2.82$2.820
Jul 14, 2025 – Jul 18, 2025$2.61$2.66$1.35$1.530
Jul 21, 2025 – Jul 25, 2025$1.52$2.84$1.47$1.970
Jul 28, 2025 – Aug 1, 2025$1.97$2.37$1.75$2.060
Aug 4, 2025 – Aug 8, 2025$2.06$2.12$1.74$1.810
Aug 11, 2025 – Aug 15, 2025$1.78$1.87$1.62$1.690
Aug 18, 2025 – Aug 22, 2025$1.69$1.82$1.57$1.750
Aug 25, 2025 – Aug 29, 2025$1.75$2.20$1.74$2.170
Sep 1, 2025 – Sep 5, 2025$2.14$2.14$1.80$1.880
Sep 8, 2025 – Sep 12, 2025$1.90$2.09$1.72$1.910
Sep 15, 2025 – Sep 19, 2025$1.89$1.95$1.68$1.760
Sep 22, 2025 – Sep 26, 2025$1.79$2.05$1.76$2.000
Sep 29, 2025 – Oct 3, 2025$2.03$2.10$1.83$1.890
Oct 6, 2025 – Oct 10, 2025$1.93$1.93$1.70$1.710
Oct 13, 2025 – Oct 17, 2025$1.71$2.25$1.67$1.700
Oct 20, 2025 – Oct 24, 2025$1.80$1.95$1.58$1.720
Oct 27, 2025 – Oct 31, 2025$1.73$1.93$1.68$1.750
Nov 3, 2025 – Nov 7, 2025$1.70$1.74$1.34$1.400
Nov 10, 2025 – Nov 14, 2025$1.49$1.53$1.25$1.250
Nov 17, 2025 – Nov 21, 2025$1.25$1.36$1.07$1.130
Nov 24, 2025 – Nov 28, 2025$1.15$1.40$1.08$1.370
Dec 1, 2025 – Dec 5, 2025$1.47$1.83$1.06$1.120
Dec 8, 2025 – Dec 12, 2025$1.10$1.20$0.94$1.130
Dec 15, 2025 – Dec 19, 2025$1.13$1.44$1.00$1.390
Dec 22, 2025 – Dec 26, 2025$1.39$1.41$1.08$1.130
Dec 29, 2025 – Jan 2, 2026$1.08$1.10$0.95$1.080
Jan 5, 2026 – Jan 9, 2026$1.08$1.26$1.06$1.090
Jan 12, 2026 – Jan 16, 2026$1.06$1.16$1.04$1.050
Jan 19, 2026 – Jan 23, 2026$1.05$1.19$1.01$1.130
Jan 26, 2026 – Jan 30, 2026$1.11$1.21$1.04$1.060
Feb 2, 2026 – Feb 6, 2026$1.04$1.24$1.03$1.130
Feb 9, 2026 – Feb 13, 2026$1.13$1.26$1.06$1.220
Feb 16, 2026 – Feb 20, 2026$1.22$1.23$1.11$1.160
Feb 23, 2026 – Feb 27, 2026$1.16$1.18$1.07$1.120
Mar 2, 2026 – Mar 6, 2026$1.09$1.10$1.00$1.020
Mar 9, 2026 – Mar 13, 2026$1.02$1.02$0.79$0.810
Mar 16, 2026 – Mar 20, 2026$0.80$0.86$0.62$0.640
Mar 23, 2026 – Mar 27, 2026$0.67$0.67$0.51$0.510
Mar 30, 2026 – Apr 2, 2026$0.53$0.83$0.49$0.700
Apr 6, 2026 – Apr 10, 2026$0.73$0.75$0.62$0.680
Apr 13, 2026 – Apr 17, 2026$0.67$0.92$0.65$0.880
Apr 20, 2026 – Apr 24, 2026$0.91$1.00$0.83$0.880
Apr 27, 2026 – May 1, 2026$0.89$0.99$0.81$0.940
May 4, 2026 – May 8, 2026$0.95$0.98$0.87$0.910
May 11, 2026 – May 15, 2026$0.88$0.99$0.82$0.960
May 18, 2026 – May 22, 2026$0.88$0.88$0.75$0.840
May 25, 2026 – May 29, 2026$0.83$0.89$0.79$0.800
Jun 1, 2026 – Jun 5, 2026$0.80$0.85$0.75$0.780
Jun 8, 2026 – Jun 12, 2026$0.77$0.80$0.66$0.660
Jun 15, 2026 – Jun 18, 2026$0.66$0.71$0.66$0.670
Jun 22, 2026 – Jun 26, 2026$0.69$0.77$0.61$0.620
Jun 29, 2026 – Jul 2, 2026$0.64$0.72$0.63$0.680
Jul 6, 2026 – Jul 10, 2026$0.68$0.74$0.67$0.690
Jul 13, 2026 – Jul 17, 2026$0.69$0.71$0.65$0.690
Jul 20, 2026 – Jul 24, 2026$0.67$0.73$0.52$0.560
Jul 27, 2026 – Jul 31, 2026$0.53$0.60$0.51$0.590
Aug 3, 2026 – Aug 7, 2026$0.64$0.89$0.55$0.750
Aug 10, 2026 – Aug 14, 2026$0.76$0.94$0.71$0.910
Aug 17, 2026 – Aug 21, 2026$0.74$0.78$0.66$0.740
Aug 24, 2026 – Aug 28, 2026$0.76$0.83$0.71$0.780
Aug 31, 2026 – Sep 3, 2026$0.82$0.82$0.72$0.790

Valuation

MetricValueUpside
IC Value
P/E-3.31
P/B1.83
P/S
EV/EBITDA-3.49
PEG-24.86
P/TBV1.83

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for CTOR, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022$10.10
2023$10.90
2024$1.44
2025$1.12

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Citius Oncology, Inc.

        Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.

        CEO
        Leonard L. Mazur
        Employees
        285
        Beta
        3.48

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for CTOR: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        CTORCitius Oncology, Inc.$0.7570.01M-3.311.83-3.49-24.861.830.00%0.00%0.00%-54.42%-49.69%-26.72%0.08-107.890.560.080.0113.33%-4446.73%-6.69%-0.11-11.60%0.00%0.00%4.78%-3.48-14.92-1.04
        ACTUActuate Therapeutics Inc$1.1327.04M-2.426.79-1.856.790.00%0.00%0.00%-553.75%336.56%-190.35%0.05-1110.882.392.310.57-67.48%-12.07%-35.69%-3.37287.35%0.00%0.00%7.64%-1.83-2.14-14.75
        FATEFate Therapeutics, Inc.$2.60303.05M$12.98+399%-1.020.6720.91-0.100.67-94.12%-2222.45%-2051.08%-51.84%-143.19%-35.89%0.385.795.67-0.25-29.88%-51.24%-9.36%-80.61%-2.94-108.62%0.00%0.00%12.94%-0.09-0.121.98-6.85
        FBRXForte Biosciences, Inc.$76.611.57B-56.7364.53-56.5264.530.00%0.00%0.00%-122.28%646.72%-96.13%0.003.883.751.13-61.30%65.67%-1.30%-2.45466.78%0.00%0.00%1.39%-54.61-75.66102.65
        LNSRLENSAR Inc$5.8371.6M$33.88+481%-3.44-4.532.02-3.44-67.00-3.7746.41%-42.06%-58.66%929.88%115.78%-49.78%-0.111.150.600.345.13%9.24%513.49%-12.66%-0.3770.25%0.00%0.00%0.00%-4.17-6.881.75-2.97
        MCRBSeres Therapeutics, Inc.$5.0148.47M13.421.7396.9011.561.73-423.83%-11910.14%721.93%19.64%-120.44%4.10%1.882.562.393.78-103.39%-100.58%1.13%0.061.11%0.00%0.00%30.93%-1.21131.39144.05-11.34
        OWLTOwlet, Inc.$5.5099.52M$15.79+187%-81.4688.5129.64-87.27-47.9592.1550.64%-7.81%-37.54%-539.76%99.55%-56.93%0.37-2.421.851.320.63169.88%35.43%-7.49%-0.35%-0.24133.44%0.00%0.00%0.45%-376.55-280.9229.4333.86
        SCLXScilex Holding Company$6.5255.36M$15.27+134%-0.16-0.271.88-0.50-0.18-0.2049.68%-900.09%-1185.78%179.18%223.04%-156.67%-0.64-23.760.080.05-0.3687.75%-46.54%-80.36%6.47%0.01-3.02%0.00%0.00%0.00%-0.6648.455.90-7.32
        SPROSpero Therapeutics, Inc.$1.2672.96M$21.25+1,586%16.862.452.4212.132.45100.00%-0.04%14.38%16.31%-0.24%9.55%0.057.597.40-4.23-111.81%24.27%-46.15%-8.73%-1.42-131.62%0.00%0.00%0.00%-4465.11-8.491.801.48
        VORVor Biopharma Inc.$22.271.21B-0.19-0.810.46-0.18-0.810.00%0.00%0.00%2057.65%128.16%-229.31%-0.0218.2018.080.57107.35%43.81%-107.71%-5.6749.54%0.00%0.00%257.46%0.862.22-4.87

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.79) − 1 = — (IC, example).